Andere Kunden interessierten sich auch für
![The therapeutic strategy for obesity-associated Mets and T2DM]( "The therapeutic strategy for obesity-associated Mets and T2DM")
The therapeutic strategy for obesity-associated Mets and T2DM16,99 €![Strategies for the development of therapeutic communication]( "Strategies for the development of therapeutic communication")
Strategies for the development of therapeutic communication29,99 €![Health Design Thinking]( "Health Design Thinking")
Health Design Thinking13,99 €![Rational Experimental Design: Development of Gene Therapeutic Strategy]( "Rational Experimental Design: Development of Gene Therapeutic Strategy")
Rational Experimental Design: Development of Gene Therapeutic Strategy46,99 €![Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids]( "Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids")
Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids146,99 €![Family Health Strategy in relation to user care]( "Family Health Strategy in relation to user care")
Family Health Strategy in relation to user care26,99 €![Community-based prevention strategy for acute diarrheal diseases]( "Community-based prevention strategy for acute diarrheal diseases")
Community-based prevention strategy for acute diarrheal diseases29,99 €
In molecular medicine, for many years, manipulation of disease genes for therapeutic reason has been a major subject. The focus has been on manipulation of gene expression at the level of DNA to change mRNA espression. For reasons of therapeutic feasibility, often expression of mRNA is increased or decreased via viral vectors. However, these strategies rely on resident genetic manipulation and often have unexpected side effects after longer treatment. Therefore, the search for protein therapies, i.e. strategies manipulating the protein expression of a target disease gene has gained attention in bio-medical research. A novel way to manipulate protein expression is to manipulate components of the ribosome, a two subunit molecular ensemble translating mRNAs into proteins. Here, we study a mutation in the LAMB3 gene, encoding a component of a trimeric anchor protein Laminin 322, which links the epidermis and dermis of the skin. LAMB3 R635X harbours a premature termination codon (PTC), which during translation is recognized by the ribosome with concomitant stop of protein synthesis and loss of the protein.